Prostate Cancer Imaging With Radioactive Tracer and Ultrasound Detector Compared to MRI and ProstaScint

Status unconfirmed · Early Phase 1

Conditions studied: Prostate Cancer

In brief

This is a small study to determine if probe, similar to an ultrasound probe, can detect prostate cancer more specifically than other imaging studies in patients with a positive prostate cancer biopsy.

Key facts

Study ID

NCT01394042

Run by

Radiological Associates of Sacramento Medical Group Inc.

People needed

12

Starts

2011-06-01

Expected to finish

2012-03-01

Last updated by the study team

2011-07-14

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Primary prostate cancer proven by sextant prostate biopsy
• Transrectal ultrasound (TRUS)-guided prostate biopsy within 6 months of study enrollment
• Sufficient time period to complete imaging protocol and 5-7 day safety followup assessment without other therapeutic intervention
• In the judgement of principal investigator, patient able to provide informed consent and be compliant with protocol requirements
• ECOG status of 0 or 1 Pt > 18 yrs of age

You may not qualify if…

• Definitive or concomitant therapeutic intervention within the interval of study intervention
• Prior pelvic therapeutic radiation
• Active malignancy or therapy for malignancy with 6 months other than basal or squamous cell carcinoma of the skin
• Pt received radiopharmaceutical which was within 5 half-lives at the time of studying imaging
• Known history of human-anti-murine-antibodies or known allergic reaction to previously received murine based products

Where it is running

• Roseville PET and Nuclear Imaging Center — Roseville, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.